These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical significance of neurocysticercosis in endemic villages. The Cysticercosis Working Group in Peru. García HH; Gilman RH; Tsang VC; Gonzalez AE Trans R Soc Trop Med Hyg; 1997; 91(2):176-8. PubMed ID: 9196761 [TBL] [Abstract][Full Text] [Related]
23. Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population. Villarán MV; Montano SM; Gonzalvez G; Moyano LM; Chero JC; Rodriguez S; Gonzalez AE; Pan W; Tsang VC; Gilman RH; Garcia HH; Neuroepidemiology; 2009; 33(1):25-31. PubMed ID: 19325247 [TBL] [Abstract][Full Text] [Related]
24. High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru. Moyano LM; O'Neal SE; Ayvar V; Gonzalvez G; Gamboa R; Vilchez P; Rodriguez S; Reistetter J; Tsang VC; Gilman RH; Gonzalez AE; Garcia HH; PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005130. PubMed ID: 27992429 [TBL] [Abstract][Full Text] [Related]
25. Neurocysticercosis among People Living Near Pigs Heavily Infected with Cysticercosis in Rural Endemic Peru. Garvey BT; Moyano LM; Ayvar V; Rodriguez S; Gilman RH; Gonzalez AE; Garcia HH; O'Neal SE; For The Cysticercosis Working Group In Peru Am J Trop Med Hyg; 2018 Feb; 98(2):558-564. PubMed ID: 29210354 [TBL] [Abstract][Full Text] [Related]
26. Epilepsy and neurocysticercosis in a village in Huaraz, Peru. Garcia HH; Talley A; Gilman RH; Zorrilla L; Pretell J Clin Neurol Neurosurg; 1999 Dec; 101(4):225-8. PubMed ID: 10622449 [TBL] [Abstract][Full Text] [Related]
27. The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review. Gripper LB; Welburn SC Infect Dis Poverty; 2017 Apr; 6(1):31. PubMed ID: 28376856 [TBL] [Abstract][Full Text] [Related]
28. Neurocysticercosis: Diagnostic problems & current therapeutic strategies. Rajshekhar V Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530 [TBL] [Abstract][Full Text] [Related]
30. The societal cost of Taenia solium cysticercosis in Tanzania. Trevisan C; Devleesschauwer B; Schmidt V; Winkler AS; Harrison W; Johansen MV Acta Trop; 2017 Jan; 165():141-154. PubMed ID: 26756713 [TBL] [Abstract][Full Text] [Related]
31. Neurocysticercosis: new thoughts on controversial issues. Del Brutto OH Curr Opin Neurol; 2013 Jun; 26(3):289-94. PubMed ID: 23493161 [TBL] [Abstract][Full Text] [Related]
32. Brain calcification because of neurocysticercosis: a vast field to be explored. Bustos JA; Coyle CM Curr Opin Infect Dis; 2020 Oct; 33(5):334-338. PubMed ID: 32868513 [TBL] [Abstract][Full Text] [Related]
33. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. Monteiro L; Almeida-Pinto J; Stocker A; Sampaio-Silva M J Neurol; 1993 Nov; 241(1):15-21. PubMed ID: 8138816 [TBL] [Abstract][Full Text] [Related]
34. From seizures to epilepsy and its substrates: neurocysticercosis. Singh G; Burneo JG; Sander JW Epilepsia; 2013 May; 54(5):783-92. PubMed ID: 23621876 [TBL] [Abstract][Full Text] [Related]
35. Pediatric Neurocysticercosis. Singhi P; Saini AG Indian J Pediatr; 2019 Jan; 86(1):76-82. PubMed ID: 28929415 [TBL] [Abstract][Full Text] [Related]
36. Antiepileptic drugs for seizure control in people with neurocysticercosis. Sharma M; Singh T; Mathew A Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722 [TBL] [Abstract][Full Text] [Related]
37. Model systems for investigating disease processes in neurocysticercosis. de Lange A; Mahanty S; Raimondo JV Parasitology; 2019 Apr; 146(5):553-562. PubMed ID: 30430955 [TBL] [Abstract][Full Text] [Related]